ProShares Ultra NASDAQ Biotechnology
29 hedge funds and large institutions have $42.3M invested in ProShares Ultra NASDAQ Biotechnology in 2014 Q4 according to their latest regulatory filings, with 15 funds opening new positions, 9 increasing their positions, 3 reducing their positions, and 3 closing their positions.
Holders
29
Holders Change
+12
Holders Change %
+70.59%
% of All Funds
0.77%
Holding in Top 10
2
Holding in Top 10 Change
+2
Holding in Top 10 Change %
%
% of All Funds
0.05%
New
15
Increased
9
Reduced
3
Closed
3
Calls
$5.97M
Puts
$13.6M
Net Calls
-$7.64M
Net Calls Change
+$1.55M
Top Buyers
1 |
AP
1
Advisors Preferred
Rockville,
Maryland
|
$7.6M |
2 |
2
Jane Street
New York
|
$5.05M |
3 |
OPPM
3
Opus Point Partners Management
New York
|
$4.79M |
4 |
TRCT
4
Tower Research Capital (TRC)
New York
|
$3.19M |
5 |
5
Morgan Stanley
New York
|
$1.73M |